A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

Abstract Background Ramucirumab has recently proved to be effective for advanced or recurrent gastric cancer (AGC). Ascites and peritoneal metastasis are among the most common complications of AGC. However, there are few data on the safety and efficacy of paclitaxel plus ramucirumab in patients with...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hiroshi Matsumoto, Akihito Kawazoe, Kaoru Shimada, Shota Fukuoka, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Atsushi Ohtsu, Takayuki Yoshino, Toshihiko Doi, Kohei Shitara
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2018-01-01
Col·lecció:	BMC Cancer
Matèries:	Gastric cancer Ascites Progression-free survival Paclitaxel Ramucirumab
Accés en línia:	http://link.springer.com/article/10.1186/s12885-018-4057-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!